In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Green beauty routine: Qosmedix set to introduce PLA cosmetics applicator
In New York, beauty products wholesaler Qosmedix has developed the industry’s first biobased cosmetics applicators.
Dubbed biowand, a plush doe foot lip gloss applicator...
Biodesign firm Crafting Plastics exhibits compostable stools at Miami Art Week
In Miami, an annual art and design festival featured a bioplastic, compostable stools from Slovakia studio Crafting Plastics. The design firm created several pieces...
Foodtech startup Pluri secures $6.5 million, enters cacao market via Kokomondo acquisition
In Israel Pluri Inc., a biotechnology company specializing in cell-based solutions, has received a strategic private investment of $6.5 million, led by global investor...